Moragrega-Knol Emma, Romero-Alfano Irene, Barata Carlos, Gómez-Canela Cristian
Department of Analytical and Applied Chemistry, School of Engineering, Institut Químic de Sarrià-Universitat Ramon Llull, Via Augusta 390, 08017, Barcelona, Spain.
Institute for Environmental Assessment and Water Research (IDAEA-CSIC), Jordi Girona 18, 08034, Barcelona, Spain.
Environ Pollut. 2025 Sep 15;381:126622. doi: 10.1016/j.envpol.2025.126622. Epub 2025 Jun 4.
The growing scarcity of freshwater has intensified the need for alternative water sources, which often require advanced treatments to eliminate contaminants. Among emerging pollutants, pharmaceuticals have become a significant concern due to their persistence and potential impact, making their detection essential. However, analysing these contaminants is challenging due to the extremely low concentrations at which they are present. For chemical analysis, minimal or no sample enrichment is often necessary, while bioanalysis typically requires larger sample volumes and an enrichment factor to conduct comprehensive bioassays across various endpoints. Consequently, sample preconcentration techniques for large water volumes are necessary to improve the sensitivity of subsequent toxicological experiments. In this study, a novel large volume solid-phase extraction (LV-SPE) procedure was validated and evaluated for monitoring multiple pharmaceutical compounds in water samples, while maintaining the traditional solid-phase extraction (SPE) methodology using cartridges. This method proved effective extraction and preconcentration of significant amounts of water, with recoveries between 19 % and 109 % in spiked wastewaters (except for fluvoxamine, remdesivir, tamoxifen and tetracycline, with recoveries <10 %). Furthermore, the optimization of this approach covers an expansive chemical space, enabling the capture of a diverse range of pharmaceutical compounds and enhancing the validity of toxicological studies. Bioassays conducted with Daphnia magna juveniles and Danio rerio embryos validated the method's applicability regarding optimized exposure conditions, the absence of adverse effects from SPE blanks or solvent controls and sensitivity in detecting effects across field samples. Overall, the LV-SPE approach enhances sensitivity and reliability for evaluating pharmaceutical mixtures' risks under realistic conditions.
淡水日益稀缺,这加剧了对替代水源的需求,而替代水源通常需要先进的处理工艺来去除污染物。在新兴污染物中,药物因其持久性和潜在影响而成为一个重大问题,因此对其进行检测至关重要。然而,由于这些污染物的存在浓度极低,分析它们具有挑战性。对于化学分析,通常需要极少的样品富集或无需样品富集,而生物分析通常需要更大的样品体积和富集因子,以便在各种终点进行全面的生物测定。因此,需要采用针对大量水样的样品预浓缩技术来提高后续毒理学实验的灵敏度。在本研究中,一种新型的大体积固相萃取(LV-SPE)方法得到了验证和评估,用于监测水样中的多种药物化合物,同时保留了使用柱管的传统固相萃取(SPE)方法。该方法被证明能有效萃取和预浓缩大量水样,在加标废水中的回收率在19%至109%之间(氟伏沙明、瑞德西韦、他莫昔芬和四环素除外,回收率<10%)。此外,该方法的优化涵盖了广阔的化学空间,能够捕获多种药物化合物,提高了毒理学研究的有效性。用大型溞幼体和斑马鱼胚胎进行的生物测定验证了该方法在优化暴露条件下的适用性、SPE空白或溶剂对照不存在不利影响以及在检测现场样品中的影响时的灵敏度。总体而言,LV-SPE方法提高了在实际条件下评估药物混合物风险的灵敏度和可靠性。